Wu Yifang, Executive Director, Chairman, Chief Executive Officer at Fosun Pharma, Shanghai, Shanghai. See sector focus and contact routes.
Fosun Pharma, established in 1994, is a globalized pharmaceutical and healthcare industry group rooted in China and driven by innovation. Its directly operated businesses include pharmaceuticals, medical devices and medical diagnostics, and healthcare services. Through its stake in Sinopharm Holdings, it also covers the pharmaceutical distribution and retail sector. The company focuses on patient-centric and clinical needs-oriented approaches, enriching its innovative product pipeline through independent R&D, collaborative development, licensed-in products, and in-depth incubation. It aims to enhance its research and clinical development capabilities for FIC (First-in-class) and BIC (Best-in-class) new drugs, accelerating the R&D and commercialization of innovative technologies and products.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Shanghai.
Investors like Wu Yifang · Full investor directory · Investor access · Company funding database